AmeriSource/Bergen
Executive Summary
Federal Trade Commission requests additional information regarding proposed merger of AmeriSource and Bergen Brunswig, companies state May 7. The merger, announced March 19, would create the largest drug wholesaler (1"The Pink Sheet" March 26, p. 5)
You may also be interested in...
AmeriSource/Bergen FTC review
"The Federal Trade Commission's second request" on the proposed merger between AmeriSource and Bergen "is broad in nature and covers nearly all facets of the business of both companies," AmeriSource tells employees in a Q&A on the merger. In May, the two companies reported that FTC had requested additional information regarding the transaction, which would create the largest drug wholesaler (1"The Pink Sheet" May 14, In Brief)
AmeriSource/Bergen FTC review
"The Federal Trade Commission's second request" on the proposed merger between AmeriSource and Bergen "is broad in nature and covers nearly all facets of the business of both companies," AmeriSource tells employees in a Q&A on the merger. In May, the two companies reported that FTC had requested additional information regarding the transaction, which would create the largest drug wholesaler (1"The Pink Sheet" May 14, In Brief)
AmeriSource Expects Post-Merger Market Share Of 33% To Pass FTC Review
AmeriSource and Bergen Brunswig predict the Federal Trade Commission will accept their combined 33% market share in the drug wholesaling sector without initiating an antitrust challenge.